Last reviewed · How we verify

NCT07060469

Comparison Between Anatomic Shoulder Arthroplasty, Hemiarthroplasty, and Reverse Shoulder Arthroplasty.

Not yet recruiting Last updated 11 July 2025
What this trial tests

trial in Shoulder Osteoarthritis in 110 participants. Not yet recruiting.

Timeline
31 July 2025
Primary endpoint
31 December 2025
31 December 2025

Quick facts

Lead sponsorRobert Jones and Agnes Hunt Orthopaedic and District NHS Trust
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment110
Start date31 July 2025
Primary completion31 December 2025
Estimated completion31 December 2025

Conditions studied

Sponsor

Robert Jones and Agnes Hunt Orthopaedic and District NHS Trust — full company profile →

Who can join

70 and older, any sex, with Shoulder Osteoarthritis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to evaluate outcomes in patients over 70 years of age who underwent anatomic shoulder arthroplasty, hemiarthroplasty, or reverse shoulder arthroplasty, focusing on revision rates, rotator cuff integrity as primary and Oxford Shoulder Scores as secondary outcome measures.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Shoulder Osteoarthritis

Currently open trials in the same condition.

Other Robert Jones and Agnes Hunt Orthopaedic and District NHS Trust trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07060469.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing